Polyclonal Antibodies
Anti-COCH Rabbit Polyclonal Antibody for IHC-P, IF/ICC, ELISA - O43405
Item Number : CM0030670
Price varies based on specs and customizations
- Application
- IHC-P, IF/ICC, ELISA
- Cross Reactivity
- Human
- Protein Weight
- 59kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | COCH Rabbit pAb |
| Remarks/Alias | DFNA9; COCH5B2; DFNB110; COCH-5B2; COCH |
| Species | Human |
| Gene ID (human) | 1690 |
| Gene ID | 1690 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 20-260 of human COCH (NP_001128530.1) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | IHC-P, IF/ICC, ELISA |
| Cross Reactivity | Human |
| SWISS | O43405 |
| Protein Weight | 59kDa |
| Shipping | Ice bag |
Biological Background: COCH Function and Localization
- Cochlin, also known as COCH-5B2, is encoded by the COCH gene in humans and exists as multiple isoforms due to alternative splicing.
- Functions in the regulation of cell shape and motility, particularly within the trabecular meshwork of the eye.
- Predominantly expressed in the inner ear structures, including the cochlea and vestibule, where it is secreted into the extracellular matrix.
- Subcellular localization is primarily extracellular, as a component of the extracellular matrix, following secretion.
- Contains a signal peptide, disulfide bonds, and glycosylation sites, indicating post-translational modifications important for its structure and function.
- Mutations in the COCH gene are associated with autosomal dominant non‑syndromic sensorineural deafness (DFNA9), highlighting its critical role in hearing.
- The protein features vWFA (von Willebrand factor type A) domains that mediate protein‑protein interactions within the extracellular matrix.
Experimental Guidance and Technical Tips
- The immunogen encompasses amino acids 20–260 of human cochlin, corresponding to the N‑terminal region following the signal peptide; this region includes the first vWFA domain and a portion of the intervening sequence.
- For IHC‑P, we recommend using formalin‑fixed, paraffin‑embedded human inner ear or trabecular meshwork tissue sections. Antigen retrieval with citrate buffer (pH 6.0) may enhance staining.
- For IF/ICC, fixation with 4% paraformaldehyde followed by permeabilization with Triton X‑100 is suggested. Titrate the antibody to determine the optimal working dilution.
- In ELISA applications, the antibody can be used as a capture or detection reagent; optimal coating concentrations and detection dilutions should be validated empirically.
- As this is a polyclonal antibody, batch‑to‑batch consistency should be confirmed for quantitative assays.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio supports diagnostic developers and researchers with a comprehensive portfolio of IVD raw materials, including validated antibody pairs and optimized monoclonal/polyclonal antibodies. For projects targeting cochlin and hearing-related disorders, we offer bulk reagents, ancillary proteins, and rare‑target sourcing to streamline your assay development. From concept to clinic, CamelBio bridges the gap between discovery and diagnostic manufacturing.
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!